Found 102 matching trials
Neprilysin Inhibition to Reduce Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction PHASE4 Cardiac magnetic resonance imaging (MRI) measures of myocardial interstitia...
Show More Location
Multiple Locations
Learn More & Join Trial
Development and Validation of the Prediction Model for Functional Mitral Regurgitation Regression in Heart Failure Patients Taking Guideline-directed Medical Therapy N/A This observational study is to develop and validate the prediction model fo...
Show More Location
Sun-Yatsen Memorial Hospital
Learn More & Join Trial
Six Months Clinical and Echocardiographic Outcome of ARNI LCZ696 Therapy in HFrEF Patients N/A To evaluate the clinical and echocardiographic outcome of LCZ696 therapy in...
Show More Learn More & Join Trial
Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCC PHASE4 The purpose of this study was to evaluate the effect of sacubitril/valsarta...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Sacubitril/Valsartan vs Lifestyle in Hypertrophic Cardiomyopathy PHASE2 The overall aim of this project is to establish potential benefits of a nov...
Show More Location
University Hospital Regensburg
Learn More & Join Trial
A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential Hypertension PHASE2 The purpose of this study is to assess the long-term safety, tolerability a...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
PHARM Optimal-HF Pilot NA The goal if this pilot randomized controlled trial is to determine the feas...
Show More Location
St. Paul's Hospital
Learn More & Join Trial
[177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-neoB Lesion Uptake PHASE1 First in Human (FIH) study to characterize the safety, tolerability, pharma...
Show More Learn More & Join Trial
The Comparative Effectiveness Between ARNI and ACE Inhibitor/ARB Medication in Patient With HFrEF N/A This study aimed to evaluate the effectiveness, safety, and cost-effectiven...
Show More Location
Yonsei University Wonju College of Medicine
Learn More & Join Trial
Combined PEX, Rituximab and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations PHASE1 This is an open-label Phase I/II trial to assess the feasibility and safety...
Show More Location
University of Pittsburgh Medical Center
Learn More & Join Trial